A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis

Background. Erythropoiesis-stimulating agents (ESAs) such as epoetin alfa and beta, and darbepoetin alfa have improved the management of anaemia secondary to chronic kidney disease. Numerous studies have reported a dose reduction when patients receiving dialysis were converted from epoetin to darbep...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonafont, Xavier, Bock, Andreas, Carter, Dave, Brunkhorst, Reinhard, Carrera, Fernando, Iskedjian, Michael, Molemans, Bart, Dehmel, Bastian, Robbins, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
In-Depth Clinical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421401/
https://www.ncbi.nlm.nih.gov/pubmed/25949339
http://dx.doi.org/10.1093/ndtplus/sfp097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421401/
https://www.ncbi.nlm.nih.gov/pubmed/25949339
http://dx.doi.org/10.1093/ndtplus/sfp097

Ejemplares similares